| Andrew S. Boyer |
Andrew S. Boyer is currently the Director at the Association for Accessible Medicines. He is also the Chief Commercial Officer-Generics & Executive VP at Amneal Intermediate, Inc. and Amneal Pharmaceuticals, Inc. Previously, Mr. Boyer served as the President & Chief Executive Officer at Teva Pharmaceuticals USA, Inc. He also held positions as the Associate Director-Marketing at Generics Group, Inc., National Accounts Manager at Wyeth Holdings LLC, Senior Vice President-Sales & Marketing at Actavis, Inc., and Marketing Manager at Barr Laboratories, Inc.Mr. Boyer completed his undergraduate degree at the State University of New York at Albany. |
| Nikita Shah |
Nikita Shah is currently the Chief Human Resources Officer & Executive VP at Amneal Intermediate, Inc. and Amneal Pharmaceuticals, Inc. She previously held the position of Head-Human Resources & Internal Audit at Warner Chilcott Co., Inc. and Senior VP-Human Resources & Corporate Affairs at Amneal Pharmaceuticals LLC. Ms. Shah is a graduate of Gujarat University. |
| Srinivas Kone |
Srinivas Kone has worked as a Senior VP-Global Generic Research & Development at Amneal Pharmaceuticals, Inc. since 2005. |
| Richard D’Souza |
Richard D’Souza currently works at Amneal Pharmaceuticals, Inc., as Senior VP-Specialty Research & Development. |
| Chintu Patel |
Chintu Patel was the founder of Amneal Pharmaceuticals LLC (founded in 2002) where he served as Co-Chairman & Co-Chief Executive Officer from 2012 to 2017. He was also the founder of Amneal Intermediate, Inc. (founded in 2002) where he served as Co-Chairman from 2018 to 2019. Additionally, Dr. Patel is the founder of Amneal Pharmaceuticals, Inc. (founded in 2002) where he currently holds the position of Co-Chief Executive Officer & Director. Dr. Patel is also the founder of Prolong Pharmaceuticals LLC, Asana BioSciences LLC, and Avtar Investments LLC. In his current roles, Dr. Patel is the Chief Executive Officer at Adello Biologics LLC since 2018. He is also a Director at Long Island University, Long Island Association, Inc., Make-A-Wish Foundation, Inc., and Creo Pharma Ltd. since their respective job starts. Dr. Patel's former positions include being the Chief Executive Officer at Kashiv Biosciences LLC and a Senior Level Manager at Eckerd Corp. from 1994 to 2002. Dr. Patel's education history includes completing his undergraduate degree at Rutgers State University of New Jersey. |
| Paul M. Meister |
Paul M. Meister founded Liberty Lane Acquisition Corp. in 2008, where he worked as President & Chief Executive Officer from 2008 to 2010, Thermo Fisher Scientific, Inc. in 1998, where he worked as Chairman from 2006 to 2007, Perspecta Trust LLC in 2007, where he is working as Vice Chairman from 2007, and various other companies. Mr. Meister also currently works at Chemtrade Solutions LLC, as Vice Chairman, Arbor Biotechnologies, Inc., as Chairman, Amneal Intermediate, Inc., as Chairman from 2019, and various other companies. Mr. Meister also formerly worked at Ventiv Health, Inc., as Chairman & Chief Executive Officer from 2010 to 2015, Thermo Electron Corp., as Chairman, Fisher Scientific International, Inc., as Vice Chairman from 2001 to 2006, and various other companies. Mr. Meister received his Masters Business Admin degree from Northwestern University and undergraduate degree from the University of Michigan. |
| Anastasios G. Konidaris |
Anastasios G. Konidaris is currently the Director at Zep, Inc., Director at Kadmon Corp. LLC, Executive VP, Chief Financial & Accounting Officer at Amneal Intermediate, Inc., and Chief Financial Officer & Executive Vice President at Amneal Pharmaceuticals, Inc. Formerly, he served as an Independent Director at Delcath Systems, Inc., Independent Director at Kadmon Holdings, Inc., Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc., Chief Financial Officer, Director & Executive VP at Alcresta Therapeutics, Inc., Group Vice President at Schering-Plough Corp., Chief Financial Officer & Senior Vice President at The Dun & Bradstreet Corp., CFO, Executive VP & Head-Corporate Development at Ikaria, Inc., and Vice President-Finance-North America at Pharmacia Corp. Mr. Konidaris holds an MBA from Drexel University and an undergraduate degree from Gwynedd-Mercy College. |
| Sanjay Kumar Jain |
Sanjay Kumar Jain currently works in Amneal Pharmaceuticals, Inc. as the President-India Operations. |
| Chirag K. Patel |
Chirag K. Patel is the founder of Amneal Pharmaceuticals LLC, Amneal Intermediate, Inc., and Amneal Pharmaceuticals, Inc. He held the title of Co-Chairman & Co-Chief Executive Officer at Amneal Pharmaceuticals LLC from 2013 to 2017. He was also a Co-Chairman at Amneal Intermediate, Inc. from 2018 to 2019. Currently, Dr. Patel is the President, Co-Chief Executive Officer & Director of Amneal Pharmaceuticals, Inc. In addition to his founding positions, Dr. Patel is also the founder of NEXTGEN Technologies Ltd, Veriprise Wireless Corp., and Avtar Investments LLC. Dr. Patel's current job(s) include being a Director at Liberty Science Center, The Art of Living Foundation, Family Reach Foundation, Creo Pharma Ltd., New Jersey City University Foundation, Win Foundation, Niswarth International Foundation, and a Trustee at Foundation for Morristown Medical Center. Dr. Patel's former job includes being a Director at Association for Accessible Medicines. Dr. Patel's education history includes undergraduate degrees from New Jersey City University, Gujarat University, and H. A. College of Commerce. |
| Ted C. Nark |
Ted C. Nark is the founder of Complete Office Solutions, which was founded in 2003. He is currently the Chairman at West Edge Partners LLC since 2022 and the Managing Director at KRG Capital LLC since 2007. He also holds director positions at Western Window Systems LLC, Convergint Technologies LLC, Metal-Era LLC, Trafficware LLC, Inventus LLC, Barentz (Ohio), Amneal Intermediate, Inc., and Amneal Pharmaceuticals, Inc. He is the President of PetroChoice Holdings, Inc. Mr. Nark previously served as the Chief Executive Officer of White Cap Industries Corp. from 2000 to 2002 and Winc Australia Pty Ltd. (New South Wales) from 1998 to 2002. He has also held director positions at Leslie's Poolmart, Inc., FTD, Inc., Gaia, Inc., FTD Group, Inc., Real Goods Solar, Inc., Fort Dearborn Co., White Cap Construction Supply, Inc., Lindy Office Products, Inc., Claim Jumper Restaurants LLC, and Nature's Trees, Inc. Additionally, he was the Group President at Corporate Express, Inc. from 1994 to 1997 and an Operating Partner at Leonard Green & Partners LP from 2006 to 2007. Mr. Nark obtained his undergraduate degree from Washington State University. |
| J. Kevin Buchi |
J. Kevin Buchi is currently the Chairman at Ampio Pharmaceuticals, Inc. and the Independent Non-Executive Director at Benitec Biopharma Ltd., Amneal Intermediate, Inc., Benitec Biopharma, Inc., and Amneal Pharmaceuticals, Inc. He previously held positions as the President, Chief Executive Officer & Director at Cephalon, Inc., BioSpecifics Technologies Corp., TetraLogic Pharmaceuticals Corp., and Dicerna Pharmaceuticals, Inc. He also served as the Director at Encysive Pharmaceuticals, Inc., Aptose Biosciences, Inc., Impax Laboratories LLC, Alexza Pharmaceuticals, Inc., Celator Pharmaceuticals, Inc., Stemline Therapeutics, Inc., Arana Therapeutics Ltd., ChemGenex Pharmaceuticals Pty Ltd., Mesoblast Ltd., Alaunos Therapeutics, Inc., Forward Pharma A, Zalicus, Inc., EPIRUS Biopharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. Mr. Buchi received his undergraduate degree from Cornell University in 1976 and his graduate degree from Kellogg School of Management in 1980. |
| John J. Kiely |
John J. Kiely is an Independent Director at Zovio, Inc., Covis Pharmaceuticals, Inc., Amneal Intermediate, Inc., and Amneal Pharmaceuticals, Inc. He previously worked as an Assurance Chief Quality Officer at PricewaterhouseCoopers LLP. He received his undergraduate degree from Saint Francis University. |
| Emily Peterson Alva |
Emily Peterson Alva is currently an Independent Director at Alkermes Plc, a Compliance Director at the Center for Drug Evaluation, a Director at Robotic Research OpCo LLC, a Director at the Mission Society of New York City, an Independent Director at Amneal Pharmaceuticals, Inc. starting in 2023, a Member at PathNorth, Inc., a Partner at the Center for Board Excellence, and a Member at Extraordinary Portfolios LLC. Previously, Ms. Alva worked as a Director at Barnard College, an Independent Director at Atlanta Life Insurance Co., a Director & Treasurer at the Alumnae Association of Mount Holyoke College, an Independent Director at Amneal Intermediate, Inc., and a Partner at Lazard, Inc. from 1997 to 2013. Ms. Alva completed her undergraduate degree at Barnard College and her graduate degree at Boston University School of Law. |
| Shlomo Yanai |
Shlomo Yanai currently works at Lumenis Ltd., as Chairman from 2020, Taavura Holdings Ltd., as Director, Philip Morris International, Inc., as Independent Director from 2021, and various other companies. Mr. Yanai also formerly worked at Teva Pharmaceutical Industries Ltd., as President & Chief Executive Officer from 2006 to 2012, ADAMA Agricultural Solutions Ltd., as President & Chief Executive Officer from 2003 to 2006, ADAMA Ltd., as Chief Executive Officer from 2002 to 2006, and various other companies. Mr. Yanai received his graduate degree in 1990 from George Washington University, undergraduate degree in 1983 from Tel-Aviv University, and undergraduate degree from The National War College. |
| Deborah M. Autor |
Deborah M. Autor is currently the Chief Executive Officer of Autor Strategies LLC. She is also an Independent Director at Amneal Intermediate, Inc. and Amneal Pharmaceuticals, Inc. Ms. Autor's former jobs include being the Chairman of the FDA Alumni Association, an Independent Director at Pardes Biosciences, Inc., Director at Antimicrobial Resistance Industry Alliance, SVP-Strategic Global Quality & Regulatory Policy at Mylan, Inc., Head-Strategic Global Quality & Regulatory Policy at Mylan NV, Vice President & Global Head-Regulatory Excellence at AstraZeneca Pharmaceuticals LP, Deputy Commissioner-Global Regulatory Operations at US Food & Drug Administration, and Trial Attorney-Consumer Litigation at US Department of Justice. Ms. Autor received her undergraduate degree from Barnard College and her graduate degree from Boston University School of Law. |
| Jeffrey P. George |
Jeffrey P. George is currently the Chairman at LENZ Therapeutics, Inc., Chairman at Lykos Therapeutics, Inc., Chairman at Education Opens Doors, Inc., Director at Dorian Therapeutics, Inc., Independent Director at Amneal Intermediate, Inc., Independent Director at Amneal Pharmaceuticals, Inc., Director at Young Presidents' Organization, Dallas Chapter, Independent Director at 908 Devices, Inc., Director at North Texas Food Bank, Operating Advisor at Revival Healthcare Capital LLC, Partner at Bridge Builders Collaborative, and Managing Partner at Maytal Capital LLC. He previously served as the Chief Executive Officer & Director at Performance Health Holdings, Inc., Chief Executive Officer at Alcon AG, Chairman at Ypo, Inc., Director at WishBone Medical, Inc., Director at Roam Analytics, Inc., Senior Director-Strategy & Business Development at Gap, Inc., Head-Sandoz Division at Novartis AG, Head-Emerging Markets at Novartis Pharmaceuticals Corp., and Engagement Manager at McKinsey & Co., Inc. Mr. George holds an MBA degree from Harvard Business School, a graduate degree from The Johns Hopkins University, and an undergraduate degree from Carleton College. |
